Amrize Ltd (NYSE:AMRZ) Sees Significant Growth in Short Interest

Amrize Ltd (NYSE:AMRZ) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totaling 6,787,840 shares, a growth of 14.3% from the March 31st total of 5,938,933 shares. Currently, 1.2% of the company’s stock are sold short. Based on an average daily trading volume, of 2,181,267 shares, the days-to-cover ratio is currently 3.1 days.

Amrize Stock Performance

Shares of NYSE:AMRZ traded down $0.44 during midday trading on Friday, hitting $53.34. The company’s stock had a trading volume of 2,589,512 shares, compared to its average volume of 2,504,586. The stock has a market capitalization of $29.50 billion and a price-to-earnings ratio of 25.52. The stock’s 50 day simple moving average is $57.86 and its 200 day simple moving average is $54.87. Amrize has a fifty-two week low of $44.12 and a fifty-two week high of $65.94. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.10 and a current ratio of 1.64.

Amrize (NYSE:AMRZ) last released its earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share for the quarter, missing the consensus estimate of ($0.14) by ($0.02). Amrize had a net margin of 9.70% and a return on equity of 9.88%. The company had revenue of $2.18 billion during the quarter. Amrize’s revenue was up 4.7% on a year-over-year basis. As a group, research analysts anticipate that Amrize will post 2.76 earnings per share for the current year.

Amrize Cuts Dividend

The business also recently announced a dividend, which will be paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th will be paid a $0.11 dividend. The ex-dividend date is Tuesday, May 12th. Amrize’s dividend payout ratio (DPR) is presently 3.35%.

Key Stories Impacting Amrize

Here are the key news stories impacting Amrize this week:

• Positive Sentiment: Vertical Research upgraded AMRZ from “hold” to “buy” and set a $70 price target (≈31% upside vs. current price), which may support upside momentum. The Fly / TickerReport
• Positive Sentiment: Company reaffirmed shareholder-friendly actions: announced a quarterly dividend (record May 12) and outlined plans to begin a previously-approved share repurchase program after Q1 results — items that can underpin the stock. (Company release / earnings commentary)
• Positive Sentiment: Significant insider and institutional buying highlighted by recent disclosures (multiple insider purchases and large institutional additions), which investors often view as a bullish signal. Quiver Quant
• Neutral Sentiment: Truist lowered its price target from $75 to $65 but maintained a “buy” rating — reduces upside vs. prior target but still constructive. Benzinga
• Neutral Sentiment: RBC trimmed its target slightly from $61 to $60 and moved to “sector perform”, a modestly less bullish stance that may temper short-term upside. Benzinga
• Neutral Sentiment: Analyst consensus remains mixed but centered around a median target near $66; recent reports show a range of targets from the mid-$50s to $75, so analyst views are varied and could drive volatility as investors pick which estimates to follow.
• Negative Sentiment: Q1 results: revenue grew but EPS missed estimates and the Building Envelope (roofing) segment showed weaker demand, margin pressures and a temporary plant disruption — factors that explain recent selling pressure. Seeking Alpha – Q1 presentation
• Negative Sentiment: Market reaction and analysis pointed to seasonal Q1 cash burn and concerns about roofing demand that drove a prior intra-day slide; near-term sentiment may remain sensitive to guidance, margin recovery and cash-flow cadence. Quiver Quant

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on AMRZ shares. Citigroup raised their price target on Amrize from $63.00 to $67.00 and gave the company a “buy” rating in a research report on Thursday, January 8th. Berenberg Bank set a $70.00 price target on Amrize in a research report on Thursday, February 19th. JPMorgan Chase & Co. raised their price target on Amrize from $60.00 to $70.00 and gave the company an “overweight” rating in a research report on Thursday, March 5th. Wells Fargo & Company lowered their price target on Amrize from $66.00 to $65.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 15th. Finally, Bank of America set a $58.00 price target on Amrize in a research report on Monday, January 12th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $64.29.

Insider Activity

In other Amrize news, insider Jaime Hill bought 3,184 shares of the stock in a transaction on Monday, March 9th. The shares were purchased at an average cost of $56.34 per share, with a total value of $179,386.56. Following the completion of the transaction, the insider directly owned 26,000 shares of the company’s stock, valued at $1,464,840. This represents a 13.96% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CTO Roald Brouwer bought 3,000 shares of the stock in a transaction on Wednesday, March 11th. The shares were acquired at an average cost of $58.72 per share, for a total transaction of $176,160.00. Following the completion of the transaction, the chief technology officer directly owned 16,257 shares of the company’s stock, valued at approximately $954,611.04. The trade was a 22.63% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last three months, insiders acquired 77,834 shares of company stock valued at $4,511,344. Corporate insiders own 0.54% of the company’s stock.

Institutional Investors Weigh In On Amrize

Several hedge funds have recently made changes to their positions in AMRZ. MCF Advisors LLC bought a new stake in shares of Amrize in the fourth quarter valued at about $27,000. State of Wyoming bought a new stake in Amrize in the 3rd quarter valued at $32,000. Basepoint Wealth LLC acquired a new position in shares of Amrize in the 4th quarter valued at $33,000. Laurel Wealth Advisors LLC bought a new position in shares of Amrize during the 4th quarter worth about $34,000. Finally, US Bancorp DE acquired a new stake in shares of Amrize during the 3rd quarter valued at about $38,000.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.